Literature DB >> 7259928

The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.

D S Reeves, D W Bullock, M J Bywater, H A Holt, L O White, D P Thornhill.   

Abstract

1 Cefoxitin was given by acute intravenous injection to six healthy volunteers, in a crossover study to investigate the effects of concurrent probenecid administration. 2 Serum antibiotic concentrations were determined by microbiological assay. Cefoxitin concentrations were simultaneously determined in the fluid of blisters produced by topical cantharides. All antibiotic was accounted for in the urine. 3 Cefoxitin was administered by intravenous infusion, subsequent to a loading dose, to produce steady state levels in the region of 10 microgram/ml, in one volunteer. The procedure was later repeated after prior administration of probenecid in the same subject. 4 Pharmacokinetic analyses indicated significant changes only in the parameters associated with renal excretion of drugs. Clearance was reduced by half. 5 The absolute and relative amounts of antibiotic in the central and peripheral compartments were calculated for both modes of administration. In the acute study probenecid produced a small change in distribution away from the peripheral or tissue compartment, towards the central compartment. 6 There was no elevation of initial serum concentrations and sustained levels of antibiotic could be accounted for principally by retarded excretion produced by probenecid, with little contribution by alteration in the disposition of antibiotic. 7 The sustained serum levels of cefoxitin that resulted from its decreased excretion were also reflected in blister fluid. It was concluded that the sustained cefoxitin levels produced by probenecid resulted in similar raised levels in the peripheral or "tissue' compartment, since the redistribution away from the peripheral compartment did not contribute materially to other changes in disposition of drug.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259928      PMCID: PMC1401675          DOI: 10.1111/j.1365-2125.1981.tb01132.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Cefoxitin in abdominal sepsis.

Authors:  A M Geddes; R M Wilcox
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

2.  Antibacterial activity, pharmacokinetics and efficacy of cefoxitin in patients with abdominal sepsis and other infections.

Authors:  P Wilson; T Leung; J D Williams
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

Review 3.  Cefoxitin, a semi-synthetic cephamycin: a microbiological overview.

Authors:  J Birnbaum; E O Stapley; A K Miller; H Wallick; D Hendlin; H B Woodruff
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

4.  Inhibition of penicillin transport from the cerebrospinal fluid after intracisternal inoculation of bacteria.

Authors:  R Spector; A V Lorenzo
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

5.  Modification of penicillin distribution and elimination by probenecid.

Authors:  M Gibaldi; D Davidson; M E Plaut; M A Schwartz
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-05

6.  [Cefazolin, a new broad-spectrum antibiotic (author's transl)].

Authors:  C Simon; V Malerczyk; E Brahmstaedt; W Toeller
Journal:  Dtsch Med Wochenschr       Date:  1973-12-21       Impact factor: 0.628

7.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

8.  Apparent effect of probenecid on the distribution of penicillins in man.

Authors:  M Gibaldi; M A Schwartz
Journal:  Clin Pharmacol Ther       Date:  1968 May-Jun       Impact factor: 6.875

9.  Concept of a volume of distribution and possible errors in evaluation of this parameter.

Authors:  S Riegelman; J Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

10.  Effect of mode of administration on drug distribution in a two-compartment open system.

Authors:  M Gibaldi
Journal:  J Pharm Sci       Date:  1969-03       Impact factor: 3.534

View more
  6 in total

1.  The effect of induced fever on the biokinetics of norfloxacin and its interaction with probenecid in goats.

Authors:  K Jha; B K Roy; R C Singh
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

2.  Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery.

Authors:  Arantxazu Isla; Iñaki F Trocóniz; Ignacio López de Tejada; Silvia Vázquez; Andrés Canut; Jesús Muriel López; María Ángeles Solinís; Alicia Rodríguez Gascón
Journal:  Eur J Clin Pharmacol       Date:  2012-01-15       Impact factor: 2.953

3.  Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.

Authors:  M T Borin; G S Hughes; C R Spillers; R K Patel
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Influence of probenecid on serum and subcutaneous tissue fluid concentrations of benzylpenicillin and ceftazidime in human volunteers.

Authors:  B Hoffstedt; S Haidl; M Walder
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

5.  The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.

Authors:  R M Ings; D S Reeves; L O White; R P Bax; M J Bywater; H A Holt
Journal:  J Pharmacokinet Biopharm       Date:  1985-04

Review 6.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.